| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/21/2002 | DE10038639A1 New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism |
| 02/21/2002 | CA2419008A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/20/2002 | EP1180512A1 Fungicidal phenylimine derivatives |
| 02/20/2002 | CN1336912A Novel propargylether derivatives |
| 02/20/2002 | CN1336907A Process for the production of alkanediol derivatives |
| 02/20/2002 | CN1336368A Method of reducing color number of benzene anhydride |
| 02/20/2002 | CN1336367A Mercaptoone and mercaptol, and prepn. process therefor |
| 02/19/2002 | US6348627 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/19/2002 | US6348618 Beta-ketoester compounds |
| 02/19/2002 | US6348551 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium |
| 02/19/2002 | US6348474 Compounds as antidiabetic agents |
| 02/19/2002 | CA2017217C Amino acid derivative anticonvulsant |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012218A1 N-methyl-d-aspartate receptor antagonists |
| 02/14/2002 | WO2002012217A1 New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012189A1 Fused bicyclic amide compounds and medicinal use thereof |
| 02/14/2002 | WO2002012167A1 Novel araquidonic acid derivatives with affinity toward the anandamide transporter |
| 02/14/2002 | WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same |
| 02/14/2002 | WO2002012158A2 Method for catalytically producing organic substances by partial oxidation |
| 02/14/2002 | WO2001087806A3 Process for the preparation of aniline compounds |
| 02/14/2002 | WO2001074910A3 Ether-amine based polymerization catalysts, compositions and processes using same |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | WO2001044324A3 Polymerization of olefins |
| 02/14/2002 | WO2001042408A3 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 02/14/2002 | US20020019569 Oxime compounds, their use, and intermediates for their production |
| 02/14/2002 | US20020019546 Dehyration of the corresponding 5-carboxyphthalide |
| 02/14/2002 | US20020019545 Microstructure patterns for photoresists |
| 02/14/2002 | US20020019543 Thiol derivative, metallo-beta-lactamase inhibitors |
| 02/14/2002 | US20020019437 Aids therapy |
| 02/14/2002 | US20020019430 Nervous system and psychological disorders |
| 02/14/2002 | US20020019429 Antiarthritic agents; osteoporosis |
| 02/14/2002 | US20020019416 Esters and amides as pla2 inhibitors |
| 02/14/2002 | US20020019403 Inhibit amyloid protein deposits |
| 02/14/2002 | US20020019401 Psychological disorders; adjustment of dopamine concentration |
| 02/14/2002 | US20020019380 1-(6-((dimethylamino)methyl)-1-methyl-2,3,5,6-tetrahydro-1H -cyclobuta(f)indol-6-yl)cyclohexanol, for example; treating psychological disorders such as depression, panic attacks, phobias, drug abuse, as well as obesity and bulemia |
| 02/14/2002 | DE10038007A1 Neue Amino-und Amido-Diphenylether für Arzneimittel New amino and amido diphenyl ether for drugs |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419027A1 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/13/2002 | EP1178986A2 Furanone derivatives as inhibitors of cathepsin s |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178797A1 Inhibitors of impdh enzyme |
| 02/13/2002 | EP1105382B1 Method for the preparation of citalopram |
| 02/13/2002 | EP0907645B1 Process for purifying phthalide |
| 02/13/2002 | CN1335308A Neotriterpenoid and its extraction and separation process |
| 02/12/2002 | US6346630 3-Arylbenzofuranones as stabilizers |
| 02/12/2002 | US6346629 Reaction of alkyne with carbon monoxide and water and hydrogenation of furanone intermediates |
| 02/12/2002 | US6346254 Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 02/12/2002 | CA2053705C Piperazine derivatives |
| 02/07/2002 | WO2002010157A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010156A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010147A1 CONTINUOUS PROCESS FOR THE PRODUCTION OF OPTICALLY PURE (S)-β-HYDROXY-η-BUTYROLACTONE |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002009759A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | US20020016477 Novel lactone compounds having alicyclic structure and their manufacturing method |
| 02/07/2002 | US20020016473 Enantioselectivity of alpha,beta-unsaturated aldehydes |
| 02/07/2002 | US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016365 Nonsteroidal gestagens |
| 02/07/2002 | US20020016363 Novel anticancer compounds : process for their preparation and pharmaceutical compositions containing them |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016344 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016324 Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them |
| 02/07/2002 | US20020016323 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020016311 Nitrate esters and their use for neurological conditions |
| 02/07/2002 | CA2572505A1 Process and intermediate compounds for the preparation of .gamma.-lactones |
| 02/07/2002 | CA2418121A1 Antimicrobial biaryl compounds |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417444A1 Nonsteroidal inflammation inhibitors |
| 02/07/2002 | CA2416707A1 Continuous process for the production of optically pure (s)-.beta.-hydroxy-.gamma.-butyrolactone |
| 02/07/2002 | CA2415078A1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 02/06/2002 | EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides |
| 02/06/2002 | EP1178035A1 Fungicidal phenylimine derivatives |
| 02/06/2002 | EP1178031A1 Process for the preparation of organic compounds with manganese catalysts or the like |
| 02/06/2002 | EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | CN1334809A Nonsteroidal antiinflammatories |
| 02/06/2002 | CN1334808A Benzamide derivs. and their use as APOB-100 secretion inhibitors |
| 02/06/2002 | CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1334031A Use of alpha-keto-enamine derivatives as ingredient |
| 02/05/2002 | US6344558 Analgesics |
| 02/05/2002 | US6344485 Method for treating glaucoma |
| 02/05/2002 | US6344454 Contraceptive preparations,treatment of endometriosis, gynecological disorders,premenstrual symptoms, male birth control, male hrt and hormone therapy and for treating andrological disease agents. |
| 01/31/2002 | WO2002008216A1 Novel compounds and their use as glycine transport inhibitors |
| 01/31/2002 | WO2002008215A1 Hyperpolarizable organic chromophores |
| 01/31/2002 | WO2002008197A1 Biphenyl carboxamides |
| 01/31/2002 | WO2002008172A1 Process for the preparation of substituted octanoyl amides |
| 01/31/2002 | WO2001043525A3 Method for the preparation of citalopram |
| 01/31/2002 | WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens |